IGI Logo

MD & CEO, Mr. Jagdishan decides not to continue

Mr. Jagdishan has decided not to seek re-appointment as MD & CEO upon completion of his current term on 26th Oct’26, despite board’s persuasion; his exit comes after challenges on corporate governance. While the Board has not announced a successor, Mr. Kaizad Bharucha (Deputy MD) may be appointed to bring stability, and he is eligible to be in office under RBI norms until Apr’29. The bank may also put forward an external name. This event would be negative and near-term pressure may persist till succession clarity emerges, although stock is attractive at 1.4x Mar'28E core ABV, (30% discount to ICICIB) but medium-term return would hinge on strategy and execution. We trim multiple to 1.9x from 2.1x. and trim TP to INR 950 from INR 1,040. Retain ‘BUY’.

MD&CEO decides to not be re-appointed:

HDFCB informed exchanges on 29th Aug’26 that Mr. Sashidhar Jagdishan has decided not to seek reappointment as MD & CEO, upon completion of his current term. Mr. Jagdishan is scheduled to retire on 26th Oct’26, having led the bank since Oct’20. Despite board’s persuasion, Mr. Jagdishan reiterated his decision to not seek re-appointment. Board has taken note of his decision and decided to fast-track the process for selection and appointment of his successor well within time to ensure a smooth leadership transition.

Potential successor:

While Board has not announced a successor, Mr. Kaizad Bharucha (Deputy Managing Director) could be immediately appointed to bring stability, while the bank may also put forward an external name. RBI requires minimum 2 candidates for MD & CEO appointment. Mr. Bharucha has experience across retail/wholesale banking and has been on the Bank's Board since 2014. He remains eligible under RBI norms until Apr’29, when he completes the permissible 15-yr tenure as a WTD.

Corporate governance issues plaguing the bank:

The exit comes after a difficult few months for HDFCB on the corporate governance front as

(1) Mr Atanu Chakraborty quit as Chairman in Mar’26, citing concerns over the bank's practices (though an external legal review later, found no evidence to support this) 

(2) the bank Board penalised Mr. Jagdishan and Mr. Arvind Kapil (retail asset head), to the tune of INR 0.1mn each in Jul’26 for "business overreach" regarding deposit arrangements with MSRDC.

Unresolved fundamental issues to address: While transition phase post-merger had impacted the financials and core earnings quality has been stabilizing, some fundamental issues remain unresolved viz.

(1) balance sheet construct in terms of LDR

(2) lower NIM due to unfavourable incremental loan mix that has been a drag on core RoA

(3) management guidance versus actual execution.

MD&CEO succession to weigh on near-term sentiment:

This event would be negative, as stakeholders were likely pricing in an extension for Mr. Jagdishan and near-term pressure could persist until succession clarity emerges. However, the stock is attractive, valued at 1.4x Mar'28E core ABV, (~30% discount to ICICIB). Returns may be protracted, with positive traction possible once a CEO candidate is shortlisted, while strategy and execution under new CEO will be a key driver for medium-term returns.

Please refer disclaimer at https://www.plindia.com/disclaimer/

SEBI Registration No. INH000000271